Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT

Recruiting Phase 2 Interventional Study
Microtia Dysbiosis Alcohol Drinking HIV Infections Cardiovascular Diseases
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 89
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
250 (estimated)
Sponsor
Vanderbilt University Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria in your gut and these changes increase the risk of heart disease and death. This randomized controlled trial will determine whether a pill containing healthy gut bacteria can increase the number good bacteria in the gut, lower levels of in…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * HIV infected Exclusion Criteria: * Not fluent in English
Contacts

Grace Wallace, BS

615-936-5356

grace.wallace@vumc.org

CONTACT

Emily Smith, MPH

6158757253

emily.k.smith@vumc.org

CONTACT